WHO ICTRP trial

A single-centre randomised, partially blind, single dose, crossover study…

EUCTR2008-006413-25-GB · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2008-006413-25-GB
Public title A single-centre randomised, partially blind, single dose, crossover study investigating the onset of action of soothing and cooling after taking Gaviscon Peppermint liquid, Double Action Gaviscon liquid, Gaviscon Instants Oral Powder, compared to a control in subjects with heartburn following a refluxogenic meal, using the 2-stopwatch technique - Gaviscon Soothing and Cooling
Scientific title A single-centre randomised, partially blind, single dose, crossover study investigating the onset of action of soothing and cooling after taking Gaviscon Peppermint liquid, Double Action Gaviscon liquid, Gaviscon Instants Oral Powder, compared to a control in subjects with heartburn following a…
Primary sponsor Reckitt Benckiser Healthcare (UK) Limited
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Countries United Kingdom
Conditions Symptoms of heartburn
Interventions Trade Name: Gaviscon Peppermint Liquid Relief Product Name: Gaviscon Peppermint Liquid Relief Pharmaceutical Form: Oral suspension CAS Number: 9005383 Other descriptive name: SODIUM ALGINATE Concentration unit: mg milligram(s) Concentration…
Registration date Jan 19, 2009
Secondary IDs GA0821
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations